Uh Oh... 3831 Advisory Committee Meeting in October

Discussion in 'Alkermes' started by anonymous, Aug 27, 2020 at 1:15 AM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    Posted while sitting in front of TV watching Jerry Springer
     

  2. anonymous

    anonymous Guest

    Anyone notice how ever since the AD COMM said they want to concentrate on drug drug interactions of Sami at the October 9th meeting we have heard very very little of the hype about 3831 through internal communications that we were getting almost daily before the AD COMM gave us that information???

    Not a good sign. Seems like we think it will get delayed or rejected.

    Should 3831 not get approved or delayed for a year what do you think we will do? Layoffs? What sales teams would take a hit? Serious replies only please.
     
  3. anonymous

    anonymous Guest

    Should approval does not happen, we will double down on Aristide. Some persistent low performers will be nudged out, but no massive layoff, in my opinion.
     
  4. anonymous

    anonymous Guest

    Your opinion is just that, an opinion with no foundation. Worst case, take a look at impact of 5461. Stock dropped 30+%... another repeat like that puts price in single digits.... Would expect another re-org
     
  5. anonymous

    anonymous Guest

    I don’t get you folks. This is your company, that provides for your family, and it’s like you jerks are absolutely wishing that our product doesn’t get approved smh.

    I don’t get it smh.

    Shame on the regretful Alkermes colleague that hired you. You Pathetic Loser!
     
  6. anonymous

    anonymous Guest

    I don’t get you folks. This is your company, that provides for your family, and it’s like you jerks are absolutely wishing that our product doesn’t get approved smh.

    I don’t get it smh.

    Shame on the regretful Alkermes colleague that hired you. You Pathetic Loser!
     
  7. anonymous

    anonymous Guest

    Fat Chicken shit Ffhagg special olympics tard, you come drunk?
     
  8. anonymous

    anonymous Guest


    No wishing required. It will fail on it's own merits
     
  9. anonymous

    anonymous Guest

    Well, physicians get a little upset when you come in with a product that has not given ample drug interaction data and offers only slight benefit to the generic version and costs 400x's more. No I'm not excited to promote it. BTW, any truth to the rumor that extension studies show reduction in weight gain advantage vanishes 46 weeks out? I hope not!
     
  10. anonymous

    anonymous Guest

    GREAT NEWS!!!!!!!!
    Advisory board gave a favorable opinion.
     
  11. anonymous

    anonymous Guest

    We heard you are good at that! Congrats. Approval is one thing. Selling will be another.
     
  12. anonymous

    anonymous Guest


    if it was easy, a sales force wouldn’t be needed.

    Selling it is literally your job. If you can’t handle it or don’t want to, find something else to do with your time. You only get one life, might as well spend it doing what you love.
     
  13. anonymous

    anonymous Guest

    Relax man, most of these comments are from trolls that either used to work here and were terminated, or from those that were never hired due to their lack of impact and intelligence.

    Let them vent as they have no other positives in there life.
     
  14. anonymous

    anonymous Guest

    The drug is a dog.
     
  15. anonymous

    anonymous Guest

    You'd better hope not too many people take your advice. Think about it. Really think about it. Who would "love" selling a $38 per pill product that is at the very most marginally better than a 27 cent per pill generic medication? Now, would you please take back your post above or are you just one of the product managers that is nose blind to this POS?
     
  16. anonymous

    anonymous Guest

    Hey, if you don’t like it, step aside, hundreds of folks willing to take your job and likely perform better at it. I hear Amazon is looking for warehouse workers, you would be a good fit.